Outline Diagnosis of CAP Site of care? Tools for risk assessment? Diagnostic tests needed? Management of severe CAP ?
Community-Acquired Pneumonia: A Clinical case scenario Presentation A 66-year-old man accompanied by his wife, arrived at the Emergency Department complaining of shortness of breath, fever, and cough. His symptoms started 8 days ago with mild fever, cough, myalgia, headache & sore throat were he received antipyretic, antihistaminic and cough syrup after consulting his family doctor through a telephone call. Symptoms Symptoms After initial improvement, he had a worsening of symptoms starting 3 days ago with productive cough, pleuritic chest pain, fever, chills and malaise. Last night he developed dyspnea and high fever, so he decided to come to the Emergency Department today. Medical History X-smoker 2 years (30 pack years). COPD. Type 2 diabetes. Medications include Inhaled salbutamol (100 g)+ beclomethasone diproprionate (50 g) 2 puffs x 3. Sustained released theophylline (200mg cap 1x2). Gliclcazide (80mg tab. 1x1). Examination Confused. Temperature: 39.0C. Blood pressure: 120/70. Pulse rate: 120 bpm. Respiratory rate: 30 per minute. Clinical signs of right upper zone consolidation and bilateral scattered rhonchi. No cyanosis, pedal edema or jugular venous distension is noted.
Chest X-ray
Diagnosis Dose this patient have Community-Acquired Pneumonia (CAP)?
Definition of CAP
Infection of the lung parenchyma in a person who is not hospitalized or living in a long-term care facility for 2 weeks.
IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
CAP: Diagnosis
In addition to a constellation of suggestive clinical features, a demonstrable infiltrate by chest radiograph or other imaging technique, with or without supporting microbiological data, is required for the diagnosis of pneumonia.
IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
CAP Risk Factors for Pneumonia Elderly Smoking COPD Extreme weather Overcrowding Alcoholism DM Renal insufficiency CHF Chronic liver disease Immunossuppresion Loss of consciousness Seizures What is the value of CXR in CAP? Establish Dx Evaluation of severity e.g. multilobar or bilateral, pleural effusion. Co-existing conditions e.g. bronchial obstruction, abscess. Pattern Infiltrate Patterns and Pathogens CXR Pattern Possible Pathogens Lobar S.pneumoniae, Kleb, H. influ, Gram Neg Patchy Atypicals, Viral, Legionella Interstitial Viral, PCP, Legionella Cavitatory Anaerobes, Kleb, TB, S.aureus, Fungi Large effusion Staph, Anaerobes, Klebsiella Initial investigations at ER: Hgb 13.4 gm/dl, Hct 40%. WBC 15,800/l with 88% polymorphonuclear cells, 8% bands. Na+ 137 mEq/L, K+ 3.7 mEq/L. BUN 32 mg/dl, creatinine1.8 mg/dl. RBG 260 mg/dl. Arterial blood gas (room air): pH 7.38, PCO 2 53 mmHg, PO 2 58mmHg, O 2 Sat.% 89% CAP Management based on PSI Score PORT Class PSI Score Mortality % Treatment Strategy Class I No RF 0.1 0.4 Out patient Class II 70 0.6 0.7 Out patient Class III 71 - 90 0.9 2.8 Brief hospitalization Class IV 91 - 130 8.5 9.3 Inpatient Class V > 130 27 31.1 IP - ICU Would you hospitalize him?
Assess the ability to safely and reliably take oral medication & the availability of outpatient support resources CURB 65 score CURB 65 Confusion BUN 30 RR 30 BP SBP <90 /DBP <60 Age > 65 CURB 0 or 1 Home Rx CURB 2 Short Hosp CURB 3 Medical Ward CURB 4 or 5 ICU care Thorax 2003,58:377 (If study performed) <60mmHg / SO 2 <90% Pneumonia Severity Index (PSI) score Clinical Parameter Scoring Age in years Age in yrs 66 Co-morbid Illnesses Neoplasia 0 Liver Disease 0 CHF 0 CVD 0 Renal Disease 0 Clinical Parameter Scoring Clinical Findings Altered Sensorium 20 Respiratory Rate > 30 20 SBP < 90 mm 0 Temp < 35 0 C or > 40 0 C 0 Pulse > 125 per min 0 Investigation Findings Arterial pH < 7.35 0 BUN > 30 20 Serum Na < 130 0 Hematocrit < 30% 0 Blood Glucose > 250 10 Pa O 2 10 X Ray e/o Pleural Effusion 0 PSI= 146 Class V ICU Calculation of risk assessment (PSI score)
The patient was hospitalized and admitted to ICU What testing would you do?
Diagnostic testing Recommendations for diagnostic testing remain controversial. No convincing data that they improve outcomes. Outpatient setting: optional Inpatient setting: Critically ill CAP Specific pathogens (suspected)
IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
Diagnostic testing: Critically ill CAP Sputum: Gram staining and culture. Blood cultures. Urinary antigen tests for Legionella & Streptococcus pneumoniae. others FOB+BAL / Endotracheal tube aspirate Thoracentesis TNA IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
What testing would you do?
Pretreatment: Sputum: Gram staining and culture. Expectorated sputum should be deep cough specimen obtained before antibiotic treatment and it should be rapidly transported and processed within a few hours of collection.* Blood cultures (2 sets) 2 sets of blood cultures should be drawn before initiation of antibiotic therapy during the first 24 hour.* *IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
What treatment would you prescribe? Therapy Fluid / diet Antipyretics (Paracetamol IV) Sugar blood chart & Insulin accordingly Cough syrup SR theophylline Inhalation ttt salbutamol + ipratropium bromide O 2 therapy NP 2 L/min Empiric Antibiotic ttt Antibiotic General & supportive What antibiotics are appropriate?
CAP: When to start empiric therapy?
As soon as possible in ED CAP: delay-to-AB> 4h after arrival Increased mortality Increased LOS
IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
Site of Care
RF Treatment 1 Treatment 2 Treatment 3 OP No RF AZ CLR ER / Doxy OP RF FQ + M + Doxy Med Ward RF FQ + AZ 3G + AZ Etrap + M ICU RF
3G + AZ 3G + FQ FQ+ AZT Pseud Extended + Cipro / Levo 3G + AmGly + AZ 3G + AmGly + FQ
CA- MRSA + Vanco/Linezo Recommended empirical antibiotics for CAP: Inpatient, ICU ttt b-lactam plus either azithromycin or a respiratory fluoroquinolone (cefotaxime, ceftriaxone)
Levofloxacin 750mg/24h + Ceftriaxone 1gm /12h IV
IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
2 hours after ICU admission
Sputum (gram stain) Gram-positive diplococcus
Value of Gram stain First, it broadens initial empirical coverage for less common etiologies, such as infection with S. aureus or gram-negative organisms. * Second, it can validate the subsequent sputum culture result. A positive Gram stain was highly predictive of a subsequent positive culture.*
*IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
Day 3 Sputum culture & Sensitivity: Streptococcus pneumoniae Sensitive Cefotaxime, Ceftraixone and Levofloxacin. Susceptibility testing should guide antibiotic choice when results are available.
Continue on the same antibiotics
Day 3: The patient's condition began to improve, but fever persisted. Day 5: The patient was a febrile for the first time. Normal oral intake started. Cough, dyspnea grade & chest wheezes improved. Pulse 90 bpm, B/P 140/80. WBC 6,800/l with 3% bands. BUN 18 mg/dl, creatinine1.4 mg/dl, 2 PPBS 170mg/dl. O 2 Sat.% on RA: 93%. Transferred to ward.
Switch from intravenous to oral therapy? Afebrile No abnormal GIT absorption Cough & respiratory distress improved WBC returning to normal
Levofloxacin 750 mg tab/24hr IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
Day 8: Clinically stable Afebrile for 3days. CXR: partial resolution. Blood culture: No growth up till now.
CAP: Duration of Therapy?
A minimum of 5 days Afebrile for 48-72 h No more than 1 CAP- associated sign of clinical instability
IDSA /ATS Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults. Clinical Infectious Diseases 2007; 44:S2772
Day 9: Discharged and antibiotic stopped. Recommendations / pneumococcal polysaccharide vaccination / During next influenza season, influenza vaccination. / ttt COPD & DM. FU CXR after 1 week.